Today, Terapet is proud to announce the successful closing of the oversubscribed seed investment round of CHF 1 Million. This funding supports the development of our first full-scale prototype to be installed for clinical validation. This round was contributed by our new investors: EFI (Efficient Frontier Investing), Nina Capital, FSI (Fongit Seed Invest) and three angel investors, with support of Fongit. Terapet wishes to take the opportunity to thank the great team Marcus Palm, Raymond Miralbell, Didier Cowling, Antonio Gambardella (director of Fongit), Dieter Froehlich, Andreas Jacob and Gian-Luca Braggiotti. We, Terapet would also like to thank everyone who helped us to transfer our idea into a real venture: Venturelab, Venture Kick, FIT (The Foundation for Technological Innovation), Innosuisse – Swiss Innovation Agency, Geneus.ch and Switzerland Innovation Park Innovaare.
Read the press release: Terapet SA Seed Financing Round Press Release
News on the social medias:
1. Article on L’agefi
2. Article on Startupticker
4. Article on CERN-Knowledge Transfer